[Federal Register Volume 69, Number 107 (Thursday, June 3, 2004)]
[Notices]
[Pages 31410-31411]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-12460]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on March 4, 2004, Applied 
Science Labs, Division of Alltech Associates Inc., 2701 Carolean 
Industrial Drive, State College, Pennsylvania 16801, made application 
by renewal to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed below.

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Methcathinone (1237).......................  I
N-Ethylamphetamine (1475)..................  I
N,N-Dimethylamphetamine (1480).............  I
4-Methylaminorex (cis isomer) (1590).......  I
Alpha-Ethyltryptamine (7249)...............  I
Lysergic acid diethylamide (7315)..........  I
2,5-dimethoxy-4(n)-propylthiophenethylamine  I
 (2C-T-7) (7348).
Mescaline (7381)...........................  I
4-Bromo-2,5-dimethoxyamphetamine (7391)....  I
4-Bromo-2,5-dimethoxyphenethylamine (7392).  I

[[Page 31411]]

 
4-Methyl-2,5-dimethoxyamphetamine (7395)...  I
2-5-Dimethoxy-4-ethylamphetamine (7399)....  I
3,4-Methylenedioxyamphetamine (7400).......  I
N-Hydroxy-3,4-methylenedioxyamphetamine      I
 (7402).
3,4-Methylenedioxy-N-ethylamphetamine        I
 (7404).
3,4-Methylenedioxymethamphetamine (7405)...  I
Alpha-methyltryptamine (AMT) (7432)........  I
Bufotenine (7433)..........................  I
Diethyltryptamine (7434)...................  I
Dimethyltryptamine (7435)..................  I
Psilocybin (7437)..........................  I
Psilocyn (7438)............................  I
5-methxy-N,N-diisopropyltryptamine (5-MeO-   I
 DIPT) (7439).
N-Ethyl-1-phenylcyclohexylamine (7455).....  I
1-(1-Phenylcyclohexyl)pyrrolidine (PCPy)     I
 (7458).
1[1-(2 Thienyl)cyclohexyl]piperidine (7470)  I
Dihydromorphine (9145).....................  I
Normorphine (9313).........................  I
Methamphetamine (1105).....................  II
1-Phenylcylohexylamine (7460)..............  II
Phencyclidine (7471).......................  II
Phenylacetone (8501).......................  II
1-Piperidinocyclohexanecarbonitrile (8603).  II
Cocaine (9041).............................  II
Codeine (9050).............................  II
Dihydrocodeine (9120)......................  II
Benzoylecgonine (9180).....................  II
Ethylmorphine (9190).......................  II
Morphine (9300)............................  II
Noroxymorphone (9668)......................  II
------------------------------------------------------------------------

    The firm plans to manufacture small quantities of the listed 
controlled substances for reference standards.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: Federal Register Representative, 
Office of Chief Counsel (CCD) and must be filed no later than August 2, 
2004.

    Dated: May 18, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 04-12460 Filed 6-2-04; 8:45 am]
BILLING CODE 4410-09-M